Search
for
Sort by
Research 871–900 of 1000+
- Maternal PPARγ protects nursing neonates by suppressing the production of inflammatory milk
- Congenital Adrenal Hyperplasia
- Nutrition and Hair
- Adverse cutaneous reactions to soft tissue fillers – a review of the histological features
- Hormonal Therapy for Acne
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Human Epidermal Neural Crest Stem Cells (hEPI-NCSC)—Characterization and Directed Differentiation into Osteocytes and Melanocytes
- Extracellular Matrix Degradation Products and Low-Oxygen Conditions Enhance the Regenerative Potential of Perivascular Stem Cells
- Health and fertility in World Health Organization group 2 anovulatory women
- Dermatoses of Pregnancy - Clues to Diagnosis, Fetal Risk and Therapy
- SOX11 and SOX4 drive the reactivation of an embryonic gene program during murine wound repair
- Biocomposite nanofiber matrices to support ECM remodeling by human dermal progenitors and enhanced wound closure
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss
- Dermatologic manifestations of endocrine disorders
- The blastema and epimorphic regeneration in mammals
- Hair growth and rejuvenation: An overview
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Large Scale Gene Expression Profiles of Regenerating Inner Ear Sensory Epithelia
- Applications of Mesenchymal Stem Cells in Skin Regeneration and Rejuvenation
- The Use of Platelet-Rich Plasma in Aesthetic and Regenerative Medicine: A Comprehensive Review
- YAP and TAZ are essential for basal and squamous cell carcinoma initiation
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Reversing wrinkled skin and hair loss in mice by restoring mitochondrial function
- Toxic Epidermal Necrolysis
- Safety of dermatologic medications in pregnancy and lactation